Brandinium

Trademark search for:

VITABELLA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2014-05-15 — Application filed
  • 2014-10-02 — Sn assigned for sect 66a appl from ib
  • 2014-10-03 — Application filed
  • 2014-10-03 — Assigned to examiner
  • 2014-10-06 — Final disposition recorded
  • 2014-10-07 — Application filed
  • 2014-10-07 — Office action issued
  • 2014-10-07 — Office action issued
  • 2014-10-07 — Office action issued
  • 2014-10-24 — Office action issued
  • 2014-11-28 — Teas change of correspondence received
  • 2014-12-09 — Examiners amendment -written
  • 2014-12-09 — Approved for pub - principal register
  • 2014-12-09 — Examiners amendment e-mailed
  • 2014-12-09 — Notification of examiners amendment e-mailed
  • 2014-12-09 — Examiner's amendment entered
  • 2014-12-26 — Assigned to lie
  • 2015-01-23 — Previous allowance count withdrawn
  • 2015-01-28 — Approved for pub - principal register
  • 2015-02-04 — Law office publication review completed
  • 2015-02-17 — Withdrawn from pub - og review query
  • 2015-03-04 — Previous allowance count withdrawn
  • 2015-03-06 — Examiners amendment -written
  • 2015-03-06 — Approved for pub - principal register
  • 2015-03-06 — Examiners amendment e-mailed
  • 2015-03-06 — Notification of examiners amendment e-mailed
  • 2015-03-06 — Examiner's amendment entered
  • 2015-03-06 — Law office publication review completed
  • 2015-03-25 — Notification of possible opposition sent to ib
  • 2015-03-25 — Notification of notice of publication e-mailed
  • 2015-03-25 — Notice of start of opposition period created, to be sent to ib
  • 2015-04-10 — Notification processed by ib
  • 2015-04-14 — Published for opposition
  • 2015-04-14 — Official gazette publication confirmation e-mailed
  • 2015-05-13 — Extension of time to oppose received
  • 2015-07-21 — Teas post publication amendment received
  • 2015-08-05 — Assigned to petition staff
  • 2015-08-05 — Post publication amendment - entered
  • 2015-08-27 — Extension of time to oppose process - terminated
  • 2015-10-06 — Registered-principal register
  • 2015-12-17 — Teas change of correspondence received
  • 2016-01-06 — Final disposition recorded
  • 2016-03-01 — Final disposition recorded
  • 2016-03-01 — Final disposition recorded
  • 2016-03-18 — Final disposition recorded
  • 2020-08-03 — Cancellation instituted no. 999999
  • 2020-11-03 — Cancellation granted no. 999999
  • 2020-11-05 — Cancellation terminated no. 999999
  • 2020-11-05 — Cancelled section 18-partial
  • 2020-11-05 — Ttab release case to trademarks
  • 2021-06-16 — Cancellation instituted no. 999999
  • 2021-09-09 — Cancellation granted no. 999999
  • 2021-12-06 — Cancelled section 18-partial
  • 2021-12-07 — Cancellation terminated no. 999999
  • 2021-12-07 — Ttab release case to trademarks
  • 2022-04-22 — Cancelled section 71
  • 2022-12-22 — Total invalidation of reg ext protection created
  • 2023-02-15 — Total invalidation of reg ext protection sent to ib
  • 2023-02-15 — Invalidation processed
  • 2023-03-13 — Total invalidation processed by the ib
  • 2023-05-29 — Correction transaction received from ib
  • 2023-06-27 — Correction from the ib examined, no action is needed
  • 2024-05-15 — Final status recorded
  • 2024-12-06 — Death of international registration

Owner Information

ANDREA PEROSINO
Turin IT
ANDREA PEROSINO
Turin IT
ANDREA PEROSINO
Turin IT

Correspondent

ANDREA PEROSINO
VIA CASTEGGIO, 10
TURIN, I10131
ITALY

Filing Details

Filing Date:
2014-05-15
Status Date:
2024-05-15
Category:
Pharmaceuticals
Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.